GLP1 medications are moving rapidly from niche treatment to mainstream force, with implications that stretch far beyond weight loss alone
Specifically, protein is important, according to a neurology and general practice physician
When used in patients experiencing lower GI symptoms while taking GLP-1 medications, ARM allows clinicians to: Differentiate between drug-related motility effects and true pelvic floor dysfunction Quantify the severity of anorectal dysfunction to support diagnosis and treatment planning Establish a baseline prior to initiating biofeedback or behavioral therapy Monitor progress if conservative management is pursued Persistent Constipation in GLP-1 Users ARM can determine if dyssynergic defecation is contributing to delayed evacuation, guiding appropriate therapy beyond simply adjusting medication
A GP surgerys refusal to administer an injection a day early often stems from a rigid interpretation of the standard maintenance schedule, rather than a flexible approach that accounts for individual patient needs and symptoms
Thirty-two adult male rats were randomly assigned to four groups (n = 8 each): Sham (SH), Ischemiareperfusion (I/R), post-conditioning (PC), and platelet-rich plasma-post conditioning PRP/PC
Researchers learned what the side effects are, and what happens when you stop taking it, when you stay on it, and when you dose up, Cleek said